Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator

類似資料

• Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy
  著者:: Niravath, Polly, 等
  出版事項: (2017)
• Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women
  著者:: Dunbier, Anita K., 等
  出版事項: (2010)
• Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
  著者:: Howell, Anthony, 等
  出版事項: (2004)
• Deficits in plasma oestradiol measurement in studies and management of breast cancer
  著者:: Dowsett, Mitch, 等
  出版事項: (2005)
• Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
  著者:: Pfeiler, G, 等
  出版事項: (2013)